Vyriad, a gene therapy company based in Rochester, has raised $85 million to support its new VV-169 cancer treatment which ...
Scientists have found a way to fine-tune a central fat-control pathway in the liver, reducing harmful blood triglycerides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback